Brussels, 28/11/2013 (Agence Europe) - The European Medicines Agency (EMA) is working on a project assessing the benefits and risks of vaccines for health. Its objective is to set up a framework across Europe which will give better overall view. The project, named ADVANCE (Accelerated Development of Vaccine Benefit-risk Collaboration in Europe), will be developed over five years with the support of the Innovative Medicine Initiative (IMI), and the active collaboration of the European Centre...